首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinica e investigacion en arteriosclerosis

缩写:

ISSN:0214-9168

e-ISSN:1578-1879

IF/分区:1.9/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引627
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Miguel García Samuelsson,Pedro Juan Tárraga López,Ángel Arturo López González et al. Miguel García Samuelsson et al.
Objective: To analyze lipid profiles and sociodemographic factors associated with atherogenic risk in obese workers classified as metabolically healthy (MHO) or unhealthy (MNHO). ...
David Gabriel David-Pardo,Julián E Barahona-Correa,Nancy M Herrera-Leaño et al. David Gabriel David-Pardo et al.
Background and aims: The internet is a major source of health information, with platforms like YouTube® and Facebook® widely used by patients to learn about diseases and treatments. However, the reliability of content o...
Pedro Javier Tárraga Marcos,Ángel Arturo López-González,Emilio Martínez-Almoyna Rifá et al. Pedro Javier Tárraga Marcos et al.
The article evaluates the atherogenic risk in 44,939 Spanish healthcare professionals by identifying the variables associated with this risk. It explains atherogenesis as the key pathological process in the development of cardiovascular dis...
Juan Pedro-Botet Juan Pedro-Botet
In addition to low-density lipoproteins (LDL), those containing apolipoprotein (Apo) B and with a diameter less than 70 nm, including the smaller triglyceride-rich lipoproteins, remnant particles, and lipoprotein(a), may independently contr...
Alessandra Franze&#x;,Emma Plana,Nuria Jiménez-Hernández et al. Alessandra Franze&#x; et al.
Introduction: The potential involvement of pathogens in the development of atherosclerosis has been studied for decades. Some previous studies have successfully identified the presence of pathogens in the atheromatous pla...
Ovidio Muñiz-Grijalvo Ovidio Muñiz-Grijalvo
Although hypertriglyceridemia (>150mg/dl) has been considered a risk factor for the development of atherosclerotic vascular disease, this relationship is not as linear or robust as that for LDL cholesterol, and the reduction of plasma trigl...
José López-Miranda José López-Miranda
In patients who have achieved optimal LDL-C control, there remains a residual risk of atherothrombotic cardiovascular disease (ASCVD) related to alterations in lipid metabolism, among which alterations in triglyceride-rich lipoproteins and ...
Jose Luis Díaz-Díaz Jose Luis Díaz-Díaz
Icosapent ethyl, a highly purified ester of eicosapentoic acid, is the only omega-3 fatty acid authorized by the European Medicines Agency to reduce the risk of cardiovascular events in people at risk, treated with statins and with triglyce...